| scholarly article | Q13442814 |
| P50 | author | Manuela Bartolini | Q38802804 |
| Patrizia Hrelia | Q43097748 | ||
| Vincenza Andrisano | Q56441574 | ||
| Anna Minarini | Q57078501 | ||
| P2093 | author name string | Patrizia Hrelia | |
| Carlo Melchiorre | |||
| Michela Rosini | |||
| Andrea Tarozzi | |||
| Maria L Bolognesi | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 360-363 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Rational approach to discover multipotent anti-Alzheimer drugs. | |
| P478 | volume | 48 |
| Q36202429 | 2,3-dihydro-1H-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors-synthesis, radiolabeling and biodistribution |
| Q50968585 | 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors. |
| Q38084168 | A review on cholinesterase inhibitors for Alzheimer's disease |
| Q36925910 | AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease |
| Q39867491 | Acetylcholinesterase inhibitors with photoswitchable inhibition of β-amyloid aggregation |
| Q35738142 | Advances in recent patent and clinical trial drug development for Alzheimer's disease |
| Q37079678 | Antiparkinson prodrugs |
| Q37866692 | Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors |
| Q56933230 | Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors |
| Q52654613 | Changing paradigm from one target one ligand towards multi target directed ligand design for key drug targets of Alzheimer disease: An important role of Insilco methods in multi target directed ligands design. |
| Q64885646 | Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species. |
| Q42949667 | Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors |
| Q36615734 | Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer's disease |
| Q38088283 | Huprines for Alzheimer's disease drug development |
| Q39574917 | Hybrid lipoic acid derivatives to attack prion disease on multiple fronts |
| Q38684594 | Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration |
| Q37559812 | Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease |
| Q38184970 | Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces |
| Q37063672 | Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features |
| Q38234645 | Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases. |
| Q38825382 | Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer's Disease |
| Q38842928 | New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition. |
| Q33552783 | Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors |
| Q39108867 | Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease |
| Q39848491 | Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice |
| Q36272226 | One-compound-multiple-targets strategy to combat Alzheimer's disease |
| Q53388500 | Pharmacodynamic study of FS-0311: a novel highly potent, selective acetylcholinesterase inhibitor. |
| Q37198579 | Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately? |
| Q34117168 | Potential therapeutic benefits of strategies directed to mitochondria. |
| Q37718546 | Prodrug approach for increasing cellular glutathione levels |
| Q52660268 | Profiling donepezil template into multipotent hybrids with antioxidant properties. |
| Q39038234 | Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015). |
| Q35617556 | Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease. |
| Q56984251 | Reversible human serum albumin binding of lipocrine: a circular dichroism study |
| Q41342817 | Small molecular floribundiquinone B derived from medicinal plants inhibits acetylcholinesterase activity |
| Q37272524 | Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. |
| Q58087917 | Synthesis and biological activity of N-substituted spiro[benzoxazepine-piperidine] Aβ-peptide production inhibitors |
| Q36709537 | Targeting acetylcholinesterase to treat neurodegeneration |
Search more.